MediumInfectious DiseasesCOVID-19 vaccination in immunocompromised adultca-mccqe1ca-rcpsc-im
A 64-year-old man with chronic lymphocytic leukaemia on B-cell-depleting therapy is concerned about COVID-19. According to NACI and Canadian guidance, which statement best reflects vaccination recommendations for adults who are moderately to severely immunocompromised?